re: three cheers for goldcoast.com.au (senoj)

the importent spending on a possible vaccine ( risque of reassortement not yet known ) is even more importend today
as new tamiflu investments

They know that a year production of "60 million "
RELENZA can not even cover world Health Workers needs .

First risque personnes cant be protected and as citicens we know why that bying RELENZA is restricted in most countrys.

Administrations belives to jump from a doubtful TAMIFLOP to a uncertain vaccin hides their errors.

I belive that the opposition of GSK versus RELENZA is out of BIOTA's control

Opposite it is in there power to OBLIGE GSK to informe them at a 30 days delay of all the new orders recived since first april 2009

And it would be good administration by management to informe share holders .